NDC 50102-120-01 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-01
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levonorgestrel | LEVONORGESTREL | Xiromed LLC | 626a2333-ff56-ef28-a287-b33bacc0302a | 2023-09-05 | Warnings | 5W7SIA7YZW |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | BioActive Nutritional | 3382df85-3ec5-4371-830e-4ed345b8f51b | 2023-07-14 | Warnings | 368GB5141J |
| Pneumotox | TRITICUM AESTIVUM, ALFALFA, ARNICA MONTANA, ASCLEPIAS TUBEROSA, CHAMOMILLA, ECHINACEA (ANGUSTIFOLIA), EUCALYPTUS GLOBULUS, FUCUS VESICULOSUS, HORDEUM VULGARE, IODIUM, NASTURTIUM AQUATICUM, PLANTAGO MAJOR, RAPHANUS SATIVUS, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, SYMPHYTUM OFFICINALE, LUNG (SUIS), ORYZA SATIVA, SILICEA, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, NATRUM MURIATICUM, NITRICUM ACIDUM, | BioActive Nutritional, Inc. | f8846fb1-92e5-4f8e-b3b3-bc620df90a62 | 2023-07-12 | Warnings | 368GB5141J |
| LILETTA | LEVONORGESTREL | Allergan, Inc. | aaf0eb2a-f88a-4f26-a445-0fd30176c326 | 2023-06-29 | Warnings, Adverse reactions | 5W7SIA7YZW |
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| Levonorgestrel | LEVONORGESTREL | Naari Pte Limited | be8b7ace-9af8-4417-85fa-863e19072887 | 2023-03-16 | Warnings | 5W7SIA7YZW |
| 09ac2d1c-97b5-4a05-af08-d58a0448c122 | efa6c9a7-ed87-4c86-ba37-534d55127755 | 2023-02-09 | Boxed warning, Warnings, Adverse reactions | efa6c9a7-ed87-4c86-ba37-534d55127755 | ||
| Next Choice One Dose | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 504735bd-6af9-4588-bf85-d09dbf2a7e41 | 2023-02-02 | Warnings | 5W7SIA7YZW |
| Take Action | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 78eee7c9-5ca5-45af-898f-92a2f3b2598e | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Aftera | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 53ad8dff-9134-475c-90b3-8087753e17c4 | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Plan B One-Step | LEVONORGESTREL | Foundation Consumer Healthcare LLC | 6ce6b40e-14ac-47bd-a648-ddf9e452e559 | 2023-01-31 | Warnings | 5W7SIA7YZW |
| Opcicon One-Step | LEVONORGESTREL | Sun Pharmaceutical Industries, Inc. | b67ca313-561e-471f-baf3-257b7e253c75 | 2023-01-13 | Warnings | 5W7SIA7YZW |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 368GB5141J |
| Morning After | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | f0fab784-3d28-35fb-e053-2995a90ab611 | 2022-12-29 | Warnings | 5W7SIA7YZW |
| Etonogestrel and Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | a8cc104a-d522-49ad-af54-2f312b829b61 | 2022-09-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Optionelle | LEVONORGESTREL TABLET, 1.5 MG | Strides Pharma Inc | 1c7e849c-6392-48a6-9214-907325a012e2 | 2022-09-16 | Warnings | 5W7SIA7YZW |
| Levonorgestrel Tablet, 1.5 mg | LEVONORGESTREL TABLET, 1.5 MG | Strides Pharma Inc | 98f6367e-14d2-4c7a-9418-d996f0040d22 | 2022-09-13 | Warnings | 5W7SIA7YZW |
| My Choice TM | LEVONORGESTREL | Proficient Rx LP | 165f7270-d050-4e97-b30f-107b96940d84 | 2022-09-01 | Warnings | 5W7SIA7YZW |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | LEVONORGESTREL AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | c3c00dc0-8834-45fb-9f5b-810a98cef59d | 2022-08-31 | Boxed warning, Warnings, Adverse reactions | ANDA200245 |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | Amneal Pharmaceuticals LLC | 5ee34c07-65af-42b8-a98f-e299ff90a8a1 | 2022-04-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.